
AI Robotics in Medicine
PublicTracking updates in AI Robotics in the healthcare industry
WOK Pilots BioToken; AI‑Web3 Push Deeper Into Healthcare
Monday, May 11, 2026
Three partnerships signal a parallel AI–Web3 advance across drug design, clinical operations, and payments. WOK–Novabioplus couples AI therapeutics with a BioToken model to assetize datasets and AI‑generated designs; Secai–Mila brings government‑certified voice automation into care delivery; and XRP Healthcare–Victus Global fortifies liquidity and market reach around XRPH‑enabled prescription savings. Watch whether tokenized bioassets, certified AI agents, and exchange‑driven incentives translate into measurable efficiency, faster R&D, and real patient uptake.
Tracking: Medicine Robotics · AI Medicine · AI Healthcare
1. Three Partnerships Push AI and Web3 Deeper Into Healthcare
Three new partnerships highlight accelerating convergence of AI and Web3 across healthcare operations, R&D, and payments.
WORK Medical Technology Group (NASDAQ:WOK) signed a strategic cooperation agreement with Shanghai Novabioplus Biotechnology to apply AI to protein therapeutics and antibody optimization while piloting a “BioToken” model to assetize biological datasets and AI‑generated molecular designs, extending WOK’s “Healthcare + Web3 + AI” strategy.
Montréal-based Secai partnered with Mila—Quebec’s AI institute—to infuse cutting‑edge deep learning into Voxira, its platform automating calls, scheduling, intake, and real‑time clinical documentation; Voxira Voice is the first AI voice agent to receive TGV certification from Quebec’s Ministry of Health.
Separately, XRP Healthcare teamed with Web3 venture firm Victus Global to bolster liquidity infrastructure, market expansion, and exchange growth for its XRP‑powered ecosystem following XRPHAI’s listing on MEXC and live rewards in the XRPH AI App.
Its prescription savings card offers up to 80% discounts at 68,000 U.S. pharmacies. Collectively, these moves target clinical efficiency, AI‑enabled drug design, and blockchain‑facilitated access.
Key facts:
- May 11, 2026: WORK Medical partnered with Shanghai Novabioplus on AI therapeutics and “BioToken” biological assetization.
- Secai partnered with Mila to advance Voxira’s clinical automation and real-time clinical reasoning across North America.
- Voxira Voice is the first AI voice agent with Quebec Ministry TGV certification.
- XRP Healthcare partnered with Victus Global to expand liquidity and exchange growth for its XRP ecosystem.
- XRPH Prescription Savings Card offers up to 80% discounts at 68,000 U.S. pharmacies.
Why it matters: Providers and patients could benefit from lower administrative burdens, faster documentation, and broader access to discounted medications, while biopharma gains new AI tools for protein design and potential data monetization paths. Traditional call centers, manual scribing vendors, and legacy payment rails may face pressure as compliant AI agents and blockchain-based infrastructures mature. Watch for WOK’s BioToken commercialization and governance model, Secai’s real-world deployment metrics and clinical reliability, and XRP Healthcare’s execution on liquidity and exchange expansion translating into sustained ecosystem usage.